What they were paid
Mersana Therapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $55,500 | $0 | $105,996 | — | $161,496 |
| FY2022 | $55,500 | $0 | $119,192 | $0 | $174,692 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Mersana Therapeutics, Inc. DEF 14A filed April 29, 2025, accession 0001104659-25-040448, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2024Mersana Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2024 · as the proxy prints themAudit · Compensation · Nominating/Governance
The rest of the Mersana Therapeutics board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Allene M. Diaz | Independent Director | $150,996 |
| Andrew A. F. Hack, M.D., Ph.D | Independent Director | $153,496 |
| Anna Protopapas | Independent Director | $145,996 |
| David Mott | Chair of the Board | $185,996 |
| Kristen M. Hege, M.D | Independent Director | $154,996 |
| Lawrence M. Alleva | Independent Director | $164,996 |
| Martin Huber, M.D | Director | $0 |
The full Mersana Therapeutics compensation record
free company briefThis page is one director within Mersana Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat